FDA Request for Feedback: Patient Focused Drug Development MeetingsBlog, DM, Educational, Advocacy
Update on the ABC008(Ulviprubart) IBM Clinical ProgramBlog, IBM, Educational, Clinical Trials
New CAR-T Therapy Data Show Encouraging Results in DermatomyositisBlog, DM, Educational, Clinical Trials, Treatments
Decoding CAR Therapies and Clinical TrialsBlog, ASyS, DM, IMNM, PM, Educational, Clinical Trials, Treatments
Understanding CAR T Cell TherapyBlog, ASyS, DM, IMNM, PM, Educational, Clinical Trials, Treatments
Understanding Clinical Trials in MyositisInsights and Perspectives, ASyS, DM, IMNM, PM, Educational, Webinar, Advocacy, Clinical Trials
Mitochondria First in Inclusion Body Myositis (IBM)Insights and Perspectives, IBM, Educational, Webinar, Advocacy
MyoConnect Advocacy & Education Summit: CAR T Cell TherapyInsights and Perspectives, ASyS, DM, IMNM, PM, Educational, Webinar, Advocacy, Clinical Trials, Treatments
CAR T FAQ Patient Brochure:Materials, ASyS, DM, IMNM, PM, Educational, Clinical Trials, Treatments
Standardized Interoperable Data Collection for Myositis Research: Developing Expert Consensus on Common Data Elements for Myositis Outcome MeasuresPublications, ASyS, DM, IBM, IMNM, PM, Educational, Symptoms & Diagnosis, Treatments
The caregiver burden of idiopathic inflammatory myopathiesPublications, ASyS, DM, IBM, IMNM, PM, Educational, Advocacy, Caregivers, Coping
Atlas of Care: Mapping the Invisible World of Care in MyositisMaterials, ASyS, DM, IBM, IMNM, PM, Educational, Advocacy, Caregivers, Coping











